Hoey Investments’s Gilead Sciences GILD Stock Holding History

Hoey Investments’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2	Closed	-$138	–	402
2024 Q3	$138	Hold	2	–	–	﹤0.01%	377
2024 Q2	$138	Buy	+2	New	+$133	﹤0.01%	377

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hoey Investments's GILD Position: Q4 2024 in Review

Hoey Investments sold out of Gilead Sciences (GILD) in Q4 2024, closing a stake of 2 shares — an estimated $138 sold.

Hoey Investments first reported a position in GILD in Q2 2024 and held it in 2 quarters. The position peaked at $138 in Q3 2024. 1,887 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

Hoey Investments reported no remaining Gilead Sciences position as of Q4 2024 after selling out during the quarter.
Hoey Investments sold 2 Gilead Sciences shares in Q4 2024, an estimated $138.
Hoey Investments first reported a position in Gilead Sciences in Q2 2024 and held it in 2 quarters.
Hoey Investments's Gilead Sciences position peaked at $138 in Q3 2024.
1,887 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on Hoey Investments's 13F filing for Q4 2024, filed 12 Feb 2025.